Literature DB >> 3497876

Trichomonas vaginalis NYH286 phenotypic variation may be coordinated for a repertoire of trichomonad surface immunogens.

J F Alderete.   

Abstract

Trichomonas vaginalis isolate NYH286 was fractionated with immunoglobulin G of sera from patients with trichomoniasis. Subpopulations of trichomonads with phenotypes of either patient serum-immunoglobulin G reactive (PS+) or nonreactive (PS-) were obtained. Flow cytofluorometry of PS+ and PS- subpopulations with a monoclonal antibody called C20A3 which reacts with a high-molecular-weight immunogen of T. vaginalis gave corresponding fluorescent (positive) and nonfluorescent (negative) phenotypes. No relationship was seen between PS+ and PS- phenotypes and binding of soybean agglutinin, wheat germ agglutinin, and concanavalin A, showing that PS- organisms still possessed carbohydrate moieties on their surfaces based on lectin binding. Phenotypic variation among the PS+ and PS- trichomonads was observed during in vitro growth. A positive-to-negative phenotype shift was also recorded for parasites obtained from lesions of mice subcutaneously infected with PS+ trichomonads. The involvement of surface proteins in the differential PS+ and PS- reactions was supported by soluble antigen and whole cell radioimmunoprecipitation assays. Finally, enhanced parasitism and killing of HeLa cells in monolayer cultures were observed for PS- subpopulations as compared with PS+ counterparts. The data support the idea that phenotypic variation for T. vaginalis may be coordinated for a repertoire of trichomonad immunogens and that such membrane dynamics influence expression of virulence determinants for these sexually transmitted disease agents.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3497876      PMCID: PMC260640          DOI: 10.1128/iai.55.9.1957-1962.1987

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  15 in total

1.  Pathogenicity of fresh isolates of Trichomonas vaginalis: "the mouse assay" versus clinical and pathologic findings.

Authors:  B M Honigberg; M C Livingston; J K Frost
Journal:  Acta Cytol       Date:  1966 Sep-Oct       Impact factor: 2.319

2.  Lectin analysis of surface saccharides in two Trichomonas vaginalis strains differing in pathogenicity.

Authors:  A Warton; B M Honigberg
Journal:  J Protozool       Date:  1980-11

3.  Enzyme linked immunosorbent assay for detecting antibody to Trichomonas vaginalis: use of whole cells and aqueous extract as antigen.

Authors:  J F Alderete
Journal:  Br J Vener Dis       Date:  1984-06

4.  Heterogeneity of Trichomonas vaginalis and discrimination among trichomonal isolates and subpopulations with sera of patients and experimentally infected mice.

Authors:  J F Alderete; L Suprun-Brown; L Kasmala; J Smith; M Spence
Journal:  Infect Immun       Date:  1985-09       Impact factor: 3.441

5.  Pathogenic Trichomonas vaginalis cytotoxicity to cell culture monolayers.

Authors:  J F Alderete; E Pearlman
Journal:  Br J Vener Dis       Date:  1984-04

6.  Analysis of surface saccharides in Trichomonas vaginalis strains with various pathogenicity levels by fluorescein-conjugated plant lectins.

Authors:  A Wartoń; B M Honigberg
Journal:  Z Parasitenkd       Date:  1983

7.  Specific nature of Trichomonas vaginalis parasitism of host cell surfaces.

Authors:  J F Alderete; G E Garza
Journal:  Infect Immun       Date:  1985-12       Impact factor: 3.441

8.  Identification of immunogenic and antibody-binding membrane proteins of pathogenic Trichomonas vaginalis.

Authors:  J F Alderete
Journal:  Infect Immun       Date:  1983-04       Impact factor: 3.441

9.  Techniques of axenic cultivation of Entamoeba histolytica Schaudinn, 1903 and E. histolytica-like amebae.

Authors:  L S Diamond
Journal:  J Parasitol       Date:  1968-10       Impact factor: 1.276

10.  Iron uptake and increased intracellular enzyme activity follow host lactoferrin binding by Trichomonas vaginalis receptors.

Authors:  K M Peterson; J F Alderete
Journal:  J Exp Med       Date:  1984-08-01       Impact factor: 14.307

View more
  9 in total

1.  Properties of Trichomonas vaginalis grown under chemostat controlled growth conditions.

Authors:  M W Lehker; J F Alderete
Journal:  Genitourin Med       Date:  1990-06

2.  Relatedness of structures of a major immunogen in Trichomonas vaginalis isolates.

Authors:  J F Alderete; K A Neale
Journal:  Infect Immun       Date:  1989-06       Impact factor: 3.441

Review 3.  Clinical and microbiological aspects of Trichomonas vaginalis.

Authors:  D Petrin; K Delgaty; R Bhatt; G Garber
Journal:  Clin Microbiol Rev       Date:  1998-04       Impact factor: 26.132

4.  Iron modulates phenotypic variation and phosphorylation of P270 in double-stranded RNA virus-infected Trichomonas vaginalis.

Authors:  J F Alderete
Journal:  Infect Immun       Date:  1999-08       Impact factor: 3.441

5.  Inhibition of Trichomonas vaginalis motility by monoclonal antibodies is associated with reduced adherence to HeLa cell monolayers.

Authors:  J N Krieger; B E Torian; J Hom; M R Tam
Journal:  Infect Immun       Date:  1990-06       Impact factor: 3.441

6.  Specific parasitism of purified vaginal epithelial cells by Trichomonas vaginalis.

Authors:  J F Alderete; P Demeś; A Gombosova; M Valent; M Fabusová; A Jánoska; J Stefanovic; R Arroyo
Journal:  Infect Immun       Date:  1988-10       Impact factor: 3.441

7.  Trichomonas vaginalis with a double-stranded RNA virus has upregulated levels of phenotypically variable immunogen mRNA.

Authors:  A Khoshnan; J F Alderete
Journal:  J Virol       Date:  1994-06       Impact factor: 5.103

8.  Identification and properties of Trichomonas vaginalis proteins involved in cytadherence.

Authors:  J F Alderete; G E Garza
Journal:  Infect Immun       Date:  1988-01       Impact factor: 3.441

9.  Differential Protein Expressions in Virus-Infected and Uninfected Trichomonas vaginalis.

Authors:  Ding He; Gong Pengtao; Yang Ju; Li Jianhua; Li He; Zhang Guocai; Zhang Xichen
Journal:  Korean J Parasitol       Date:  2017-04-30       Impact factor: 1.341

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.